BNB PLUS CORP (BNBX)
NASDAQFinancialsBiotechnologySnapshot 2026-09-04
$0.14-12.50%
Close 2026-08-10 · 1-day change
NASDAQFinancialsBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · BNBX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 2.4 | 2.1 | 3.4 | 13.4 | 18.2 | 9.0 | 1.9 | 5.4 | 3.9 | 4.8 | 4.2 | 9.0 | 2.7 | 2.0 | 1.9 | 1.0 |
| Total Revenues | — | — | — | — | — | — | — | 5.4 | — | 4.8 | 4.2 | 9.0 | 2.7 | 2.0 | 1.9 | 1.0 |
| Cost of Revenues | 1.0 | 1.3 | 2.4 | 7.8 | 13.1 | 4.5 | 0.7 | 0.9 | 1.2 | 1.1 | 1.2 | — | — | — | — | — |
| Gross Profit | 1.4 | 0.8 | 1.0 | 5.5 | 5.1 | 4.5 | — | — | — | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 20.5 | 10.9 | 11.4 | 12.8 | 15.1 | 12.8 | 10.0 | 10.3 | 11.0 | 13.3 | 10.8 | 13.4 | 13.2 | 11.2 | 7.6 | 8.4 |
| R&D Expenses | 4.4 | 6.0 | 3.6 | 3.7 | 3.9 | 4.2 | 3.3 | 3.0 | 2.8 | 2.3 | 3.7 | 2.6 | 1.3 | 0.7 | 0.4 | 0.3 |
| Operating Income | (34.7) | (16.0) | (14.0) | (11.0) | (14.0) | (13.3) | (12.5) | (9.1) | (11.6) | (12.8) | (12.2) | (7.9) | (12.3) | (10.2) | (6.5) | (8.1) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | — | — | — | (0.0) | 0.6 | 2.5 |
| Interest & Investment Income | 0.0 | 0.2 | 0.2 | 0.1 | — | — | — | — | — | — | — | — | — | — | — | — |
| Asset Writedown | — | — | — | — | — | — | — | — | 0.3 | 0.3 | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (36.0) | (15.6) | (7.1) | (10.0) | (8.3) | (14.3) | (13.0) | (8.6) | (11.7) | (12.9) | (12.2) | (11.9) | (13.1) | (17.7) | (7.2) | (10.5) |
| Income Tax Expense | — | (0.7) | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — |
| Earnings from Continuing Operations | (35.3) | (15.0) | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Minority Interest | (0.1) | (0.2) | (0.1) | (0.1) | (0.0) | 0.0 | (0.0) | (0.0) | — | — | — | — | — | — | — | — |
| Net Income | (35.2) | (15.2) | (7.0) | (9.9) | (8.3) | (14.3) | (13.0) | (8.6) | (11.7) | (12.9) | (12.2) | (11.9) | (13.1) | (17.7) | (7.2) | (10.5) |
| Per Share | ||||||||||||||||
| Basic EPS | (4.21) | (134.23) | (1.82) | (15.21) | (0.93) | (2.07) | (3.32) | — | — | — | — | — | — | — | — | — |
| Diluted EPS | (4.21) | (134.23) | (1.82) | (15.21) | (0.93) | (2.07) | (3.32) | — | — | — | — | — | — | — | — | — |
| Revenue per Share | 0.29 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 8.4 | 0.5 | 4.0 | 0.7 | 9.0 | 6.9 | 3.9 | — | — | — | — | — | — | — | 576.1 | — |
| Diluted Weighted Avg Shares | 8.4 | 0.5 | 4.0 | 0.7 | 9.0 | 6.9 | 3.9 | — | — | — | — | — | — | 839.6 | 576.1 | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (15.7) | (13.3) | (9.6) | (12.7) | (12.5) | (12.2) | (8.7) | (11.1) | (11.9) | (11.5) | (7.4) | (11.8) | (9.9) | (6.2) | (7.7) |
| EBIT | (34.7) | (16.0) | (14.0) | (11.0) | (14.0) | (13.3) | (12.5) | (9.1) | (11.6) | (12.8) | (12.2) | (7.9) | (12.3) | (10.2) | (6.5) | (8.1) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | -0.2% | 0.0% | 0.0% | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.